Walleye Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,335
| Closed | -$277K | – | 4382 |
|
|
2026
Q1 | $300K | Sell |
1,335
-2,623
| -66% | -$654K | ﹤0.01% | 2883 |
|
|
2025
Q4 | $953K | Sell |
3,958
-1,168
| -23% | -$299K | ﹤0.01% | 2410 |
|
|
2025
Q3 | $1.4M | Buy |
5,126
+3,524
| +220% | +$963K | ﹤0.01% | 2045 |
|
|
2025
Q2 | $413K | Buy |
1,602
+493
| +44% | +$118K | ﹤0.01% | 2772 |
|
|
2025
Q1 | $248K | Sell |
1,109
-455
| -29% | -$106K | ﹤0.01% | 2961 |
|
|
2024
Q4 | $358K | Buy |
+1,564
| New | +$377K | ﹤0.01% | 2858 |
|
|
2024
Q3 | – | Sell |
-15,132
| Closed | -$3.38M | – | 4514 |
|
|
2024
Q2 | $2.9M | Buy |
15,132
+243
| +2% | +$49.3K | 0.01% | 1375 |
|
|
2024
Q1 | $2.95M | Buy |
14,889
+12,325
| +481% | +$2.26M | 0.01% | 1475 |
|
|
2023
Q4 | $441K | Buy |
+2,564
| New | +$394K | ﹤0.01% | 3187 |
|
|
2023
Q3 | – | Sell |
-3,779
| Closed | -$683K | – | 5301 |
|
|
2023
Q2 | $826K | Buy |
3,779
+1,699
| +82% | +$379K | ﹤0.01% | 2355 |
|
|
2023
Q1 | $455K | Buy |
+2,080
| New | +$451K | ﹤0.01% | 2882 |
|
|
2022
Q3 | – | Sell |
-2,739
| Closed | -$623K | – | 5458 |
|
|
2022
Q2 | $574K | Buy |
+2,739
| New | +$583K | ﹤0.01% | 2764 |
|
|
2021
Q3 | – | Sell |
-643
| Closed | -$176K | – | 5624 |
|
|
2021
Q2 | $159K | Buy |
+643
| New | +$135K | ﹤0.01% | 4099 |
|
|
2020
Q4 | – | Sell |
-2,003
| Closed | -$399K | – | 4882 |
|
|
2020
Q3 | $343K | Buy |
+2,003
| New | +$370K | ﹤0.01% | 2566 |
|
|
2020
Q2 | – | Sell |
-600
| Closed | -$98.2K | – | 4549 |
|
|
2020
Q1 | $88K | Buy |
+600
| New | +$95.6K | ﹤0.01% | 3189 |
|
|
2019
Q4 | – | Sell |
-544
| Closed | -$78.4K | – | 4553 |
|
|
2019
Q3 | $73K | Sell |
544
-5,504
| -91% | -$721K | ﹤0.01% | 3445 |
|
|
2019
Q2 | $738K | Buy |
6,048
+4,580
| +312% | +$507K | 0.01% | 1858 |
|
|
2019
Q1 | $153K | Buy |
+1,468
| New | +$152K | ﹤0.01% | 3223 |
|
|
2018
Q4 | – | Sell |
-6,258
| Closed | -$670K | – | 5199 |
|
|
2018
Q3 | $722K | Buy |
+6,258
| New | +$685K | ﹤0.01% | 2466 |
|
|
2018
Q1 | – | Sell |
-3,821
| Closed | -$324 | – | 4740 |
|
|
2017
Q4 | $324 | Buy |
3,821
+1,684
| +79% | +$139K | ﹤0.01% | 3014 |
|
|
2017
Q3 | $164 | Buy |
2,137
+704
| +49% | +$53.9K | ﹤0.01% | 3373 |
|
|
2017
Q2 | $112 | Buy |
+1,433
| New | +$103K | ﹤0.01% | 3490 |
|
|
2017
Q1 | – | Sell |
-10,965
| Closed | -$758K | – | 5088 |
|
|
2016
Q4 | $680K | Buy |
+10,965
| New | +$672K | ﹤0.01% | 1825 |
|
|
2016
Q3 | – | Sell |
-828
| Closed | -$55.1K | – | 5330 |
|
|
2016
Q2 | $52K | Buy |
+828
| New | +$48.8K | ﹤0.01% | 3950 |
|
|
2015
Q1 | – | Sell |
-7,022
| Closed | -$456K | – | 4421 |
|
|
2014
Q4 | $394K | Buy |
7,022
+6,395
| +1,020% | +$334K | ﹤0.01% | 1766 |
|
|
2014
Q3 | $31K | Buy |
+627
| New | +$31.9K | ﹤0.01% | 3377 |
|
|
2014
Q2 | – | Sell |
-5,675
| Closed | -$281K | – | 3983 |
|
|
2014
Q1 | $254 | Buy |
+5,675
| New | +$255K | ﹤0.01% | 1755 |
|
|
2013
Q4 | – | Sell |
-1,371
| Closed | -$69.4K | – | 3774 |
|
|
2013
Q3 | $72K | Sell |
1,371
-1,305
| -49% | -$63.3K | ﹤0.01% | 2134 |
|
|
2013
Q2 | $121K | Buy |
+2,676
| New | +$127K | ﹤0.01% | 1922 |
|
Other funds holding RMD
Walleye Trading's RMD Position: Q2 2026 in Review
Walleye Trading sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,335 shares — an estimated $277K sold.
Walleye Trading first reported a position in RMD in Q2 2013 and held it in 29 quarters. The position peaked at $2.95M in Q1 2024. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Walleye Trading reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 1,335 ResMed shares in Q2 2026, an estimated $277K.
- Walleye Trading first reported a position in ResMed in Q2 2013 and held it in 29 quarters.
- Walleye Trading's ResMed position peaked at $2.95M in Q1 2024.
- 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.